Novavax Inc (NVAX)

Cost of Revenue

$14.25M

Quarterly · Period ending: · USD

NVAX logo

NVAX Cost of Revenue

Latest reported$14.25M
NVAX Quarterly Cost of Revenue (-$100.00K → $14.25M)
High-resolution chart · PNG

NVAX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
14,246,000
30,695,000
25,204,000
21,496,000
14,225,000
14,115,000
36,669,000
60,619,000
46,242,000
48,809,000
148,876,000
98,929,000
55,777,000
34,086,000
181,765,000
434,593,000
271,077,000
15,204,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,656,000
0
0
0
51,100,000
0
0
0
7,893,000
2,747,000
2,687,000
2,459,000
2,837,000
4,027,000
5,102,000
3,021,000
2,603,000
2,276,000
1,632,000
1,712,000
1,952,000
3,838,000
5,118,000
3,786,000
7,003,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,048,000
1,096,000
855,000
1,404,000
2,909,000
1,170,000
1,161,000
1,548,000
717,000
1,068,000
2,027,000
1,979,000
1,362,000
364,000
1,501,000
263,000
673,000
761,000
388,000
234,000
731,000
762,000
1,008,000
1,057,000
1,126,000
822,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.